Subpulmonary stenosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3190Q24.3
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Subpulmonary stenosis, also known as infundibular pulmonary stenosis or subvalvular pulmonary stenosis, is a congenital heart defect characterized by narrowing (stenosis) of the right ventricular outflow tract below the pulmonary valve. This obstruction occurs in the infundibular region of the right ventricle, where muscular or fibrous tissue creates a barrier to blood flow from the right ventricle to the pulmonary artery. The condition primarily affects the cardiovascular system and can occur as an isolated defect or in association with other congenital heart malformations, most notably tetralogy of Fallot. Patients with subpulmonary stenosis may present with symptoms ranging from mild to severe depending on the degree of obstruction. Key clinical features include a cardiac murmur (typically a systolic ejection murmur heard at the left upper sternal border), exertional dyspnea (shortness of breath during physical activity), fatigue, and in severe cases, cyanosis (bluish discoloration of the skin due to reduced oxygen levels). Right ventricular hypertrophy may develop over time as the heart works harder to pump blood through the narrowed outflow tract. In neonates and infants with severe obstruction, symptoms may include failure to thrive and signs of right heart failure. Diagnosis is typically made through echocardiography, which can visualize the site and severity of the obstruction, supplemented by cardiac catheterization in some cases. Treatment depends on the severity of the stenosis. Mild cases may require only monitoring, while moderate to severe cases often necessitate surgical intervention. Surgical resection of the obstructing infundibular muscle or fibrous tissue is the primary treatment approach. In some cases, balloon dilation or placement of a transannular patch may be required. Outcomes following surgical correction are generally favorable, particularly when the condition is identified and treated early.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Subpulmonary stenosis.

View clinical trials →

No actively recruiting trials found for Subpulmonary stenosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Subpulmonary stenosis community →

Specialists

1 foundView all specialists →
NM
Nathaniel Sznycer-Taub, MD
ANN ARBOR, MI
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Subpulmonary stenosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Subpulmonary stenosisForum →

No community posts yet. Be the first to share your experience with Subpulmonary stenosis.

Start the conversation →

Latest news about Subpulmonary stenosis

No recent news articles for Subpulmonary stenosis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Subpulmonary stenosis

What is Subpulmonary stenosis?

Subpulmonary stenosis, also known as infundibular pulmonary stenosis or subvalvular pulmonary stenosis, is a congenital heart defect characterized by narrowing (stenosis) of the right ventricular outflow tract below the pulmonary valve. This obstruction occurs in the infundibular region of the right ventricle, where muscular or fibrous tissue creates a barrier to blood flow from the right ventricle to the pulmonary artery. The condition primarily affects the cardiovascular system and can occur as an isolated defect or in association with other congenital heart malformations, most notably tetra

At what age does Subpulmonary stenosis typically begin?

Typical onset of Subpulmonary stenosis is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Subpulmonary stenosis?

1 specialists and care centers treating Subpulmonary stenosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.